At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 321 enrolled
Drug / intervention
sertraline +1 moredrug
Likely dose
sertraline 25mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Multicenter Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·interventional·Posted May 14, 2008·Updated Jan 27, 2021
In Brief
A Phase 4 clinical trial evaluating sertraline and Paroxetine for Panic Disorder. Completed, enrolled 321 participants across 22 sites.
Detailed Summary
To evaluate the efficacy and safety of sertraline compared to paroxetine in patients with panic disorder.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPanic Disorder
CountriesJapan
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2008
First PostedMay 2008
Primary CompletionJan 2010
Study CompletionFeb 2010
TodayJul 2026
First PostedMay 14, 2008
Enrollment StartMay 1, 2008
Primary CompletionJan 1, 2010
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 18.1 years ago
Interventions
sertralinedrug
dosage : 25mg , 50mg , placebo; dosage form : tablet; frequency : once daily after dinner; duration : 14 weeks
Paroxetinedrug
dosage : 10mg, placebo; dosage form : capsule; frequency : once daily after dinner; duration : 14 weeks